ACHE and Alzheimer disease: Complementary computational analyses have identified CA as a dual-target ligand for AChE and NMDARs, two pivotal proteins in cholinergic and excitotoxic signaling, underscoring its potential for multitarget modulation in AD, despite not consistently being the most potent binder [33].